AIDS Therapies

FDA Approves 3TC/AZT Combination

Published in AIDS Weekly, December 11th, 1995

The U.S. Food and Drug Administration (FDA) and AIDS advocates will be watching to see whether a newly approved combination of the drugs 3TC and AZT actually prolongs the lives of people with AIDS.

The FDA authorized the use of 3TC in combination with AZT, after only 4-1/2 months of review. The drug's manufacturer must now demonstrate that the therapy produces "clinical benefits," such as a reduction of opportunistic infections, the FDA said.

Glaxo Wellcome Inc., Research Triangle Park, North Carolina, makes both 3TC and AZT. It found that when the two drugs are paired, 3TC appears to boost immune systems and lower the amount of HIV in the blood...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-12-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry